Gamaleya Center has created a vaccine adapted to combat “omicron”

In Russia, a vaccine against coronavirus infection has been created, adapted to combat the Omicron strain. It was developed at the National Research Center for Epidemiology and Microbiology. N.F. Gamaleya. This was announced by the director of the center Alexander Gitsburg.

In an interview “Izvestia” he said that the drug will allow more effective protection against coronavirus, scientists say. The new vaccine targets the BA.5 virus subvariant, but also works well against the BA.1 and BA.2 subtypes.

“Yes, BA.5 has changed a lot, so the antigenic composition of the vaccine strain needs to be changed. In fact, it (the drug. – Approx. ed.) is already at the N.F. Gamaleya Institute. Now it is being discussed how to introduce it into civil circulation “– said Alexander Gunzburg.

Earlier, Life reported that Russia had acquired “its own” version of covid. This is a hybrid of strains “omicron” and “delta”. American geneticist Dmitry Pruss believes that the danger of the “Russian deltacron” has yet to be studied.


Be the first to read breaking news on Today’s latest news, and live news updates, read the most reliable English news website

Leave a Comment